p53
Showing 26 - 50 of >10,000
Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)
Suspended
- Neoplasm
- SGT-53
- +2 more
-
Houston, TexasTexas Children's Hospital
Feb 7, 2022
MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)
Recruiting
- Myelodysplastic Syndromes
- +5 more
- Sodium stibogluconate
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Jinan University
Jun 5, 2021
Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Cancer
- SGT-53
- +2 more
-
Dallas, TexasMary Crowley Cancer Research Center
Feb 7, 2022
Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)
Active, not recruiting
- Carcinoma, Squamous Cell
- +2 more
- Intensity Modulated Radiotherapy (IMRT) - deintensified
- +4 more
-
Gainesville, Florida
- +3 more
Jan 25, 2022
P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)
Recruiting
- P53 Mutation
- +3 more
- Decitabine
- Arsenic Trioxide
-
Shanghai, Shanghai, ChinaHematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021
Endometrial Cancer, Serous Tumor, P53 Mutation Trial in Toronto (Cisplatin, External Beam Radiation, Carboplatin)
Recruiting
- Endometrial Cancer
- +2 more
- Cisplatin
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 20, 2021
High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride
Completed
- High-grade Serous Ovarian Cancer
- APR-246
- Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
-
Gent, Belgium
- +11 more
Jul 19, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Carboplatin
- +2 more
-
Chicago, IllinoisNorthwestern University
Oct 13, 2021
Refractory Solid Tumors Trial in Shanghai (Arsenic trioxide)
Recruiting
- Refractory Solid Tumors
- Arsenic trioxide
-
Shanghai, ChinaDepartment of Oncology, Ruijin Hospital
May 11, 2021
Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)
Recruiting
- Malignant Salivary Gland Cancer
- Salivary Gland Cancer
-
Tampa, Florida
- +2 more
Feb 10, 2022
Arsenic Trioxide, p53 Mutations, Refractory Cancer Trial in Shanghai (Arsenic Trioxide)
Recruiting
- Arsenic Trioxide
- +3 more
- Arsenic Trioxide
-
Shanghai, ChinaDepartment of Medical Oncology, Shanghai Changzheng Hospital
Jan 4, 2021
Colorectal Carcinoma, Ulcerative Colitis Trial in Chicago (Atorvastatin Calcium, Biospecimen Collection, Placebo Administration)
Recruiting
- Colorectal Carcinoma
- Ulcerative Colitis
- Atorvastatin Calcium
- +2 more
-
Chicago, IllinoisNorthwestern University
Feb 10, 2022
Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)
Terminated
- Colorectal Cancer Metastatic
- +2 more
-
Bergen, NorwayHaukeland University Hospital
Jan 20, 2021
Short- and Medium-term Evaluation of Mastoid Filling Using
Not yet recruiting
- Cholesteatoma
- verre bioactif 45S5 GlassBONE
- verre bioactif S53P4 Bonalive
-
Lyon, Pierre-Bénite, FranceHôpital Lyon Sud
Jun 16, 2023
Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 Trial in Worldwide (APR-246, Carboplatin and
Completed
- Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
- APR-246
- Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
-
Los Angeles, California
- +54 more
Sep 20, 2022
Ovarian Cancer, Peritoneal Cavity Cancer Trial in Dallas (Ad5CMV-p53 gene)
Completed
- Ovarian Cancer
- Peritoneal Cavity Cancer
- Ad5CMV-p53 gene
-
Dallas, TexasSimmons Cancer Center - Dallas
Jan 29, 2021
CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)
Not yet recruiting
- CLL/SLL
- Orelabrutinib and BG
-
Wuhan, Hubei, China
- +1 more
Jun 15, 2023
Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)
Unknown status
- Wilms Tumor
- +2 more
- P53, Ki67 and Cyclin A IHC.
-
Mansoura, Dakahlia, EgyptMansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021
Li Fraumeni Syndrome Trial in Villejuif (whole body MRI)
Completed
- Li Fraumeni Syndrome
- whole body MRI
-
Villejuif, FranceInstitut Gustave Roussy
Feb 23, 2021
Schizophrenia Trial in Worldwide (DSP-5423P Placebo, DSP-5423P 40mg, DSP-5423P 80mg)
Completed
- Schizophrenia
- DSP-5423P Placebo
- +4 more
-
Beijing, Etc., China
- +7 more
Apr 9, 2022
Spine Fusion, Spinal Deformity Trial in Turku (S53P4 bioactive glass putty)
Active, not recruiting
- Spine Fusion
- Spinal Deformity
- S53P4 bioactive glass putty
-
Turku, FinlandTurku University Hospital Department of Neurosurgery
Aug 11, 2021